Drawing for AMNIOTIC MEMBRANE DERIVED ADHERENT CELLS

USPTO serial 77444010

AMNIOTIC MEMBRANE DERIVED ADHERENT CELLS

Reviewed by CopyMark Law Group

Reg. 3648997Status 710
Filing date
Status date
Registration date
Jun 30, 2009
Examiner
PERKINS, ELLEN J
Law office
TMO LAW OFFICE 110

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with AMNIOTIC MEMBRANE DERIVED ADHERENT CELLS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Camille M. Miller

CAMILLE M. MILLER COZEN O'CONNOR1650 MARKET STOne Liberty PlacePHILADELPHIA, PA 19103-3527

Goods and services

ClassDescriptionStatusFirst use
001Genetic testing reagents for scientific laboratory use, namely, DNA probes; adhesives for biological tissue, namely, blood stem cells, umbilical cords and placentas for scientific, laboratory and medical research; biological preparations for medical purposesSECTION 8 - CANCELLEDOct 31, 2008
005Medical and biological preparations from stem cells, stem cell tissue or stem cell scaffold, or a combination thereof, for pharmaceutical, clinical or medical laboratory use, namely, preparations that modulate the immune system; biological tissue from stem cells, stem cell tissue or stem cell scaffold, or a combination therefore intended for use as a wound covering; wound dressings; burn dressing; surgical dressing; pharmaceutical preparations from stem cells, stem tissue or stem cell scaffold, or a combination thereof for the treatment and dressing of wounds; pharmaceuticals preparations from stem cells, stem cell tissue or stem cell scaffold, or a combination thereof for use in preventing rejection of transplanted organs and tissue; and biological tissue intended for subsequent implantation, namely, blood, stem cells, umbilical cords and placentas, for medical and clinical useSECTION 8 - CANCELLEDOct 31, 2008

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 7, 2020CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jun 30, 2018REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jul 28, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 12, 2014NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jul 12, 20148.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jul 12, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 30, 2014ES8RTEAS SECTION 8 RECEIVED—
Jun 30, 2009R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
May 26, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 26, 2009CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
May 26, 2009IUAAUSE AMENDMENT ACCEPTED—
May 15, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 14, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 14, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 29, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 26, 2009AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Mar 26, 2009IUAFUSE AMENDMENT FILED—
Mar 26, 2009ALIEASSIGNED TO LIE—
Mar 25, 2009ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 25, 2009EAAUTEAS AMENDMENT OF USE RECEIVED—
Mar 25, 2009EXPIEX PARTE APPEAL-INSTITUTED—
Mar 25, 2009JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Mar 25, 2009EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Sep 29, 2008GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 29, 2008GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 29, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 27, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2008DOCKASSIGNED TO EXAMINER—
Apr 14, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance